Similar articles for PMID: 23704320

Year	Number of Results
2005	1
2006	4
2007	2
2008	1
2009	2
2010	4
2011	9
2012	14
2013	19
2014	13
2015	6
2018	1
2019	1
2020	2
2024	0

1

Hybrid imaging of peripheral skeletal disease by SPECT/high-resolution flat-panel CT.

Lohrmann C, Hauschild O, Meyer PT, Mix M, Strohm PC, Weber WA, Rischke HC. Lohrmann C, et al. J Nucl Med. 2013 Aug;54(8):1323-6. doi: 10.2967/jnumed.112.116343. Epub 2013 May 23. J Nucl Med. 2013. PMID: 23704320 Free article.

2

SPECT/CT stabilizes the interpretation of somatostatin receptor scintigraphy findings: a retrospective analysis of inter-rater agreement.

Apostolova I, Riethdorf S, Buchert R, Derlin T, Brenner W, Mester J, Klutmann S. Apostolova I, et al. Ann Nucl Med. 2010 Jul;24(6):477-83. doi: 10.1007/s12149-010-0383-9. Epub 2010 May 7. Ann Nucl Med. 2010. PMID: 20449694

3

Impact of CT attenuation correction by SPECT/CT in brain perfusion images.

Ishii K, Hanaoka K, Okada M, Kumano S, Komeya Y, Tsuchiya N, Hosono M, Murakami T. Ishii K, et al. Ann Nucl Med. 2012 Apr;26(3):241-7. doi: 10.1007/s12149-011-0567-y. Epub 2012 Jan 26. Ann Nucl Med. 2012. PMID: 22278350

4

Double-phase (131)I whole body scan and (131)I SPECT-CT images in patients with differentiated thyroid cancer: their effectiveness for accurate identification.

Wakabayashi H, Nakajima K, Fukuoka M, Inaki A, Nakamura A, Kayano D, Kinuya S. Wakabayashi H, et al. Ann Nucl Med. 2011 Nov;25(9):609-15. doi: 10.1007/s12149-011-0513-z. Epub 2011 Jul 2. Ann Nucl Med. 2011. PMID: 21725630

5

Clinical interpretation standards and quality assurance for the multicenter PET/CT trial rubidium-ARMI.

Renaud JM, Mylonas I, McArdle B, Dowsley T, Yip K, Turcotte E, Guimond J, Trottier M, Pibarot P, Maguire C, Lalonde L, Gulenchyn K, Wisenberg G, Wells RG, Ruddy T, Chow B, Beanlands RS, deKemp RA. Renaud JM, et al. J Nucl Med. 2014 Jan;55(1):58-64. doi: 10.2967/jnumed.112.117515. Epub 2013 Nov 18. J Nucl Med. 2014. PMID: 24249797 Free article. Clinical Trial.

6

131I SPECT/CT in the follow-up of patients with differentiated thyroid carcinoma.

Menges M, Uder M, Kuwert T, Schmidt D. Menges M, et al. Clin Nucl Med. 2012 Jun;37(6):555-60. doi: 10.1097/RLU.0b013e3182531dca. Clin Nucl Med. 2012. PMID: 22614186

7

Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.

Qiu ZL, Xue YL, Song HJ, Luo QY. Qiu ZL, et al. Nucl Med Commun. 2012 Dec;33(12):1232-42. doi: 10.1097/MNM.0b013e328358d9c0. Nucl Med Commun. 2012. PMID: 23111353

8

Incremental value of 111-in pentetreotide SPECT/CT fusion imaging of neuroendocrine tumors.

Wong KK, Cahill JM, Frey KA, Avram AM. Wong KK, et al. Acad Radiol. 2010 Mar;17(3):291-7. doi: 10.1016/j.acra.2009.08.015. Epub 2009 Dec 4. Acad Radiol. 2010. PMID: 19962915

9

Detection and localization of post-operative and post-traumatic bile leak: hybrid SPECT-CT with 99mTc-Mebrofenin.

Sharma P, Kumar R, Das KJ, Singh H, Pal S, Parshad R, Bal C, Bandopadhyaya GP, Malhotra A. Sharma P, et al. Abdom Imaging. 2012 Oct;37(5):803-11. doi: 10.1007/s00261-011-9840-8. Abdom Imaging. 2012. PMID: 22302118

10

Thoracic non-osseous lesions in cancer patients detected in low-dose CT images acquired as part of skeletal SPECT/CT examinations.

Wuest W, Lell M, May MS, Saake M, Kuwert T, Uder M, Linke R. Wuest W, et al. Nuklearmedizin. 2015;54(4):173-7. doi: 10.3413/Nukmed-0721-15-02. Epub 2015 Jul 13. Nuklearmedizin. 2015. PMID: 26165684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

70 results

Results by year